As of 18 Sept 2026, Parenteral Drugs (India) Ltd share price is ₹3.39. The stock opened at ₹3.39 and had closed at ₹3.24 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹3.39 and a high of ₹3.39. In terms of performance, Parenteral Drugs (India) Ltd share price has increased by 0.00% over the past six months and has increased by 0.00% over the last year.
PDPL Stock Price Chart
Parenteral Drugs (India) Ltd Overview
About PDPL
Parenteral Drugs (India) Company engaged primarily in the business of Manufacturing of Pharmaceutical Product. The Company is also engaged in trading in various products.
Parenteral Drugs (India) Ltd Historical Performance
Parenteral Drugs (India) Ltd Fundamentals
Parenteral Drugs (India) Ltd Financials
| Indicator | Mar 22 | Mar 21 |
|---|---|---|
| Revenue | 8.57 | 12.23 |
| EBITDA | 37.27 | -11.70 |
| Net Profit | -76.36 | -121.71 |
| EPS | -25.61 | -40.82 |
Parenteral Drugs (India) Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 3.24 |
| Resistance 1 (R1) | 3.24 |
| Pivot Point | 3.24 |
PDPL Key Leadership Details
Last Updated: Mar 2021
| Name | Position |
|---|---|
| Manoharlal Gupta | Chairman |
| Govind Das Garg | Whole-time Directorector |
| Dharam Pal Khanna | Independent Director |
Parenteral Drugs (India) Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,857.30+0.21% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,318.00+1.75% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,814.00+0.03% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Parenteral Drugs (India) Ltd today is ₹3.39 on NSE and ₹3.39 on BSE.
- The 52-week high of Parenteral Drugs (India) Ltd is N/A, while the 52-week low is N/A.
- The current market capitalisation of Parenteral Drugs (India) Ltd is approximately ₹10 crore.
- The P/E (Price-to-Earnings) ratio of Parenteral Drugs (India) Ltd is -0.13. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Parenteral Drugs (India) Ltd is 0.00. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Parenteral Drugs (India) Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for PDPL on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Parenteral Drugs (India) Ltd has delivered a return of approximately N/A. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Parenteral Drugs (India) Ltd comprises different categories of shareholders. As of Mar 2022, the shareholding is approximately 73.29% promoters, 0.00% FIIs, 0.00% DIIs, and 21.74% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
